Enhancement of Immunomodulatory and Anticancer Activity of Fucoidan by Nano Encapsulation

  • Qadir, Syed Abdul (Department of Biomaterials Engineering, College of Bioscience and Biotechnology, Kangwon National University) ;
  • Kwon, Min-Chul (Department of Biomaterials Engineering, College of Bioscience and Biotechnology, Kangwon National University) ;
  • Han, Jae-Gun (Department of Biomaterials Engineering, College of Bioscience and Biotechnology, Kangwon National University) ;
  • Ha, Ji-Hye (Department of Biomaterials Engineering, College of Bioscience and Biotechnology, Kangwon National University) ;
  • Jin, Ling (Department of Biomaterials Engineering, College of Bioscience and Biotechnology, Kangwon National University) ;
  • Jeong, Hyang-Suk (Department of Biomaterials Engineering, College of Bioscience and Biotechnology, Kangwon National University) ;
  • Kim, Jin-Chul (Department of Biomaterials Engineering, College of Bioscience and Biotechnology, Kangwon National University) ;
  • You, Sang-Guan (Faculty of Marine Bioscience and Technology, Kangnung National University) ;
  • Lee, Hyeon-Yong (Department of Biomaterials Engineering, College of Bioscience and Biotechnology, Kangwon National University)
  • Published : 2008.12.31

Abstract

The aim of the present study was to prepare nanosample of fucoidan using lecithin as encapsulated material and to investigate the anticancer and immunomodulatory activity of nanoparticle in vitro. The nanoparticles have been characterized by dynamic light scattering (DLS) and transmission electron microscopy (TEM). Confocal microscopy confirmed the internalization of the fucoidan conjugates into the immune cells. The uptake of nanoparticles was confirmed with confocal microscopy demonstrating their localization in the cells. The anticancer activity was increased over 5-10% in different cancer cells of fucoidan nanoparticle as compare with fucoidan. The human B and T cells growth and the secretion of interleukin-6 and tumor necrosis factor-a from B cell were also improved by fucoidan nanoparticle because of the rapid absorption of nanoparticle into the cells as compare to fucoidan. At 0.6 mg/mL concentrations, the fucoidan nanoparticle showed better activity than 1.0 mg/mL concentration in T cell growth because the cells reached their saturation capacity. When the fucoidan was encapsulated in lecithin, its anticancer as well as its immunomodulatory activity proved to be superior from that of itself in pure form.

Keywords

References

  1. Percival E, McDowell RH. Chemistry and Enzymology of Marine Algal Polysaccharides. 1st ed. Academic Press Inc., New York, NY, USA. pp.157-175 (1967)
  2. Painter TJ. Algal polysaccharides. pp. 195-285. In: Polysaccharide. Vol. 2. Molecular Biology. Aspinall GO (ed). Academic Press Inc., London, UK (1983)
  3. Nishino T, Nagumo T. Anticoagulant and antithrombin activities of oversulfated fucans. Carbohyd. Res. 229: 355-362 (1992) https://doi.org/10.1016/S0008-6215(00)90581-0
  4. Ponce NMA, Pujol CA, Damonte EB, Flores ML, Stortz CA. Fucoidans from the brown seaweed Adenocystis utricularis: Extraction methods, antiviral activity, and structural studies. Carbohyd. Res. 338: 153-165 (2003) https://doi.org/10.1016/S0008-6215(02)00403-2
  5. Patankar MS, Oehninger S, Barnett T, Williams RL, Clark GF. A revised structure for fucoidan may explain some of its biological activities. J. Biol. Chem. 268: 21770-21776 (1993)
  6. Zhuang C, Itoh H, Mizuno T, Ito H. Antitumor active fucoidan from the brown seaweed, umitoranoo (Sargassum thunbergii). Biosci. Biotech. Bioch. 59: 563-567 (1995) https://doi.org/10.1271/bbb.59.563
  7. Feldman SC, Reynaldi S, Stortz CA, Cerezo AS, Damonte EB. Antiviral properties of fucoidan fractions from Leathesia difformis. Phytomedicine 6: 335-340 (1999) https://doi.org/10.1016/S0944-7113(99)80055-5
  8. Jhamandas JH, Wie MB, Harris K, MacTavish KD, Kar S. Fucoidan inhibits cellular and neurotoxic effects of ${\beta}-amyloid\;(A{\beta})$ in rat cholinergic basal forebrain neurons. Eur. J. Neurosci. 21: 2649-2659 (2005) https://doi.org/10.1111/j.1460-9568.2005.04111.x
  9. Hsu HY, Hajjar DP, Khan KM, Falcone DJ. Ligand binding to macrophage scavenger receptor-A induces urokinase-type plasminogen activator expression by a protein kinase-dependent signaling pathway. J. Biol. Chem. 273: 1240-1246 (1998) https://doi.org/10.1074/jbc.273.2.1240
  10. Mytar B, Gawlicka M, Szatanek R. Induction of intracellular cytokine production in human monocytes/macrophages stimulated with ligands of pattern recognition receptors. Inflamm. Res. 53: 100-106 (2004) https://doi.org/10.1007/s00011-003-1233-1
  11. Anastase-Ravion S, Carreno MP, Blondin C. Heparin-like polymers modulate proinflammatory cytokine production by lipopolysaccharide-stimulated human monocytes. J. Biomed. Mater. Res. 60: 375-383 (2002) https://doi.org/10.1002/jbm.10112
  12. Mytar B, Woloszyn M, Macura-Biegun A. Involvement of pattern recognition receptors in the induction of cytokines and reactive oxygen intermediates production by human monocytes/macrophages stimulated with tumor cells. Anticancer Res. 24: 2287-2293 (2004)
  13. Baba M, Snoeck R, Pauwels R, de Clercq E. Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus. Antimicrob. Agents Ch. 32: 1742-1745 (1988) https://doi.org/10.1128/AAC.32.11.1742
  14. Beress A, Wassermann O, Bruhn T, Beress L, Kraiselburd EN, Gonzalez LV, De Motta GE, Chavez PI. A new procedure for the isolation of anti-HIV compounds (polysaccharides and polyphenols) from the marine alga Fucus vesiculosus. J. Nat. Prod. 56: 478-488 (1993) https://doi.org/10.1021/np50094a005
  15. Abou El Wafa AA, Mursi NM, El-Shaboury KM. A pharmaceutica study on certain ocular drug delivery systems. MS thesis, Cairo Univercity, Cairo, Egypt (2003)
  16. Barragan-Montero V, Winum J, Moles J, Juan E, Clavel C, Montero J. Synthesis and properties of isocannabinoid and cholesterol derivatized rhamnosurfactants: Application to liposomal targeting of keratinocytes and skin. Eur. J. Med. Chem. 40: 1022-1029 (2005) https://doi.org/10.1016/j.ejmech.2005.04.009
  17. Pavelic Z, Skalko-Basnet N, Filipovic-Grcic J, Martinac A, Jalsenjak I. Development and in vitro evaluation of a liposomal vaginal delivery system for acyclovir. J. Control Release 106: 34-43 (2005) https://doi.org/10.1016/j.jconrel.2005.03.032
  18. Mainardes RM, Silva LP. Drug delivery systems: Past, present, and future. Curr. Drug Targets 5: 449-455 (2004) https://doi.org/10.2174/1389450043345407
  19. Heurtault B, Saulnier P, Pech B, Proust J, Benoit J. Physico-chemical stability of colloidal lipid particles. Biomaterials 24: 4283-4300 (2003) https://doi.org/10.1016/S0142-9612(03)00331-4
  20. Sharma A, Sharma US. Liposomes in drug delivery: Progress and limitations. Int. J. Pharm. 154: 123-140 (1997) https://doi.org/10.1016/S0378-5173(97)00135-X
  21. Sivakumar PA, Panduranga Rao K. The use of cholesteryl pullulan for the preparation of stable vincristine liposomes. Carbohyd. Polym. 51: 327-332 (2003) https://doi.org/10.1016/S0144-8617(02)00187-X
  22. Lau KG, Hattori Y, Chopra S, O'Toole EA, Storey A, Nagai T, Maitani Y. Ultra-deformable liposomes containing bleomycin: In vitro stability and toxicity on human cutaneous keratinocyte cell lines. Int. J. Pharm. 300: 4-12 (2005) https://doi.org/10.1016/j.ijpharm.2005.04.019
  23. Gadras C, Santaella C, Vierling P. Improved stability of highly fluorinated phospholipids based vesicles in the presenceof bile salts. J. Control Release 57: 29-34 (1999) https://doi.org/10.1016/S0168-3659(98)00109-6
  24. Kokkona M, Kallinteri P, Fatouros D, Antimisiaris SG. Stability of SUV liposomes in the presence of cholate salts and pancreatic lipases: Effect of lipid composition. Eur. J. Pharm. Sci. 9: 245-252 (2000) https://doi.org/10.1016/S0928-0987(99)00064-0
  25. Kim JC, Kim JD. Release property of temperature-sensitive liposome containing poly(N-isopropylacrylamide). Colloid Surface B 24: 45-52 (2002) https://doi.org/10.1016/S0927-7765(01)00220-X
  26. Park SH, Oh SG, Mun JY, Han SS. Effects of silver nanoparticles on the fluidity of bilayer in phospholipid liposome. Colloid Surface B 44: 117-122 (2005) https://doi.org/10.1016/j.colsurfb.2005.06.002
  27. Mitry RR, Sarraf CE, Havlik R, Habib NA. Detection of adenovirus and initiation of apoptosis in hepatocellular carcinoma cells after Ad-p53 treatment. Hepatology 31: 885-889 (2000) https://doi.org/10.1053/he.2000.5631
  28. Oka M, Maeda S, Koga N, Kato K, Saito T. A modified colorimetric MTT assay adapted for primary cultured hepatocytes: Application to proliferation and cytotoxic assays. Biosci. Biotech. Bioch. 56: 1472-1473 (1992) https://doi.org/10.1271/bbb.56.1472
  29. Han BH, Park MH, Cho JY, Park JS, Yoo ES, Baik KU. Effect of ginsenosides from Panax ginseng on $TNF-{\alpha}$ production and T cell proliferation. Yakhak Hoeji 42: 296-301 (1998)
  30. Yueran Z, Rui S, You L, Chunyi G, Zhigang T. Expression of leptin receptors and response to leptin stimulation of human natural killer cell lines. Biochem. Bioph. Res. Co. 300: 247-252 (2003) https://doi.org/10.1016/S0006-291X(02)02838-3
  31. Aisa Y, Miyakawa Y, Nakazato T, Shibata H, Saito K, Ikeda Y, Kizaki M. Fucoidan induces apoptosis of human HS-Sultan cells accompanied by activation of caspase-3 and down-regulation of ERK Pathways. Am. J. Hematol. 78: 7-14 (2005) https://doi.org/10.1002/ajh.20182
  32. Liversidge GG, Cundy KC. Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in Beagle dogs. Int. J. Pharm. 125: 91-97 (1995) https://doi.org/10.1016/0378-5173(95)00122-Y
  33. Liversidge EM, Liversidge GG, Cooper ER. Nanosizing: A formulation approach for poorly-water-soluble compounds. Eur. J. Pharm. Sci. 18: 113-120 (2003) https://doi.org/10.1016/S0928-0987(02)00251-8